You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 7, July 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Epilepsy
 •Neurogenetics
 •Alert me on articles by topic

A Novel Loss-of-Function LGI1 Mutation Linked to Autosomal Dominant Lateral Temporal Epilepsy

Pasquale Striano, MD; Arturo de Falco, MD; Erica Diani, BSc; Giorgia Bovo, BSc; Sandra Furlan; Libero Vitiello, PhD; Federica Pinardi, MD; Salvatore Striano, MD; Roberto Michelucci, MD; Fabrizio Antonio de Falco, MD; Carlo Nobile, PhD

Arch Neurol. 2008;65(7):939-942.

Background  Mutations responsible for autosomal dominant lateral temporal epilepsy have been found in the leucine-rich, glioma-inactivated 1 (LGI1) gene.

Objectives  To describe the clinical and genetic findings in a family with autosomal dominant lateral temporal epilepsy and to determine the functional effects of a novel LGI1 mutation in culture cells.

Design  Clinical, genetic, and functional investigations.

Setting  University hospital and laboratory.

Patients  An Italian family with autosomal dominant lateral temporal epilepsy.

Main Outcome Measure  Mutation analysis.

Results  A novel LGI1 mutation, c.365T>A (Ile122Lys), segregating with the disease was identified. The mutant Lgi1 protein was not secreted by culture cells.

Conclusion  Our data provide further evidence that mutations in LGI1 hamper secretion of the Lgi1 protein, thereby precluding its normal function.


Author Affiliations: Muscular and Neurodegenerative Diseases Unit, Institute "G. Gaslini," University of Genoa, Genoa, Italy (Dr P. Striano); Department of Neurological Sciences, Epilepsy Center, Federico II University (Drs P. Striano and S. Striano) and Division of Neurology, Loreto Nuovo Hospital (Drs A. de Falco and F. A. de Falco), Napoli, Italy; CNR Institute of Neurosciences, Section of Padova (Mss Diani, Bovo, and Furlan and Dr Nobile) and Department of Biology, University of Padova (Dr Vitiello), Padova, Italy; and Department of Neurosciences, Ospedale Bellaria, Bologna, Italy (Drs Pinardi and Michelucci).


RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(7):871-872.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.